Oxy just cashed out OxyChem, and the Street's buzzing with Buffett worship and hot takes. 📈 The chart shows a clean breakout from $41 to $42+ on heavy volume, with the 9-period EMA pulling ahead—bullish momentum. RSI at 59 says there's room to run, not overheated. With the deal done and focus shifting to shareholder returns, this looks like a coiled spring. BUY the narrative and the breakout. #BuffettBonus

Buffett's legend is fueling the buzz, but the tape tells a calmer story. 📰 The stock popped on high volume, but now it's cooling off with an "eh" RSI and the short-term WMA is just napping above the long-term one. Feels like the hype is digesting the move. I'm not buying the frenzy yet—this needs to consolidate. Hold and watch. #BuffettEffect

Buffett's forever-stock spotlight is heating up OXY! 📈 The chart shows it's consolidating after a pop, with the 9-period EMA nudging above the 21—a subtle bullish tilt. RSI is dead-neutral at 51, so no overbought fatigue. The real story? Record production, shrinking debt, and big funds loading up. This isn't a frenzy; it's a strategic build. Looks like a steady BUY for the patient holder. #BuffettVibes

Oxy's earnings beat and Buffett buzz are the real story! 📈 Technically, it's consolidating after that pop – RSI is neutral, volume's healthy. This looks like a coiled spring. Big money is accumulating and the news flow is relentlessly positive. I'm calling this a BUY on any dip. #DrillBabyDrill

Buffett's $9.7B OxyChem deal is a massive vote of confidence! 🐂 But the stock got whacked on the news, with the 9-day WMA diving below the 21-day. RSI is flirting with oversold territory at 43, suggesting the panic selling might be overdone. This feels like a classic "buy the rumor, sell the news" flush. I'm calling it a BUY on this weakness. Buffett just showed his hand, and I'm betting with him. #SmartMoney

"Buffett’s blessing + DAC hype = OXY’s got swagger! 🚀 News is bullish (hello, ADNOC joint venture and cash flow glow-up), but the stock’s taken a breather—RSI cooling from 60s to mid-50s (no fever here). WMAs are still cozy, though. Chart shows a little afternoon slump today, but volume’s steady. Buy the dip—this Warren-backed cash cow’s got legs. #BuffettBounce"

"Buffett’s blessing + solid earnings? OXY’s got momentum! 🚀 The 9-day WMA just crossed above the 21-day—bullish signal—and RSI is a comfy 56, no overbought panic yet. Volume spiked on the earnings beat, and the chart’s recovering from that wild dip last week. News says cash flow’s king, and the Street’s buzzing. BUY the Buffett halo effect before it’s priced in. #EnergyCashCow"

"Buffett’s blessing is still lifting OXY like a helium balloon 🎈—even as he steps back! The stock’s been on a tear, with WMAs curling up and RSI flirting with 60 (not screaming, just whispering 'moar'). Volume’s juicy on up days, and the chart’s got that 'staircase to heaven' vibe. News is all cash flow love and earnings beats. BUY this Buffett-backed beast—dip or no dip. #BuffettMagic"

**Analysis:** Occidental (OXY) is showing mixed signals 📊. The stock’s recent bounce from ~$35.67 (Apr 11) to ~$38.03 suggests short-term bullish momentum, but it’s still below both the 9-day and 21-day EMAs, indicating longer-term resistance. RSI has climbed from oversold (~32) to neutral (~38), hinting at potential upside if buying continues. Volume spiked during the dip (Apr 10), but recent trading is lighter—caution ahead. News is noisy (Buffett bets, oil prices), but earnings on May 7 could be a catalyst. **Verdict:** Hold for now, watch for a break above $39. 🛢️